Short Communication - (2025) Volume 9, Issue 3
Received: 01-Sep-2025, Manuscript No. rtr-25-173559;
Editor assigned: 03-Sep-2025, Pre QC No. P-173559;
Reviewed: 17-Sep-2025, QC No. Q-173559;
Revised: 20-Sep-2025, Manuscript No. R-173559;
Published:
29-Sep-2025
, DOI: 10.37421/2684-4273.2025.9.129
Citation: Martínez-Lopez, Sofia. ”Thyroid C Cells: Plasticity, Pathogenesis, Therapy.” Rep Thyroid Res 09 (2025):129.
Copyright: © 2025 Martínez-Lopez S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
This review offers a clear picture of how thyroid C cells, also known as parafollicular cells, originate, develop, and adapt. Understanding their remarkable plasticityâ??their ability to change and respond to different physiological needsâ??is key for understanding thyroid function and the progression of related diseases, like medullary thyroid carcinoma. It connects early development and later disease states.[1] This article challenges the idea that calcitonin-producing C-cells are only about calcitonin. It highlights their multifaceted roles, suggesting they contribute to thyroid physiology in ways beyond just calcium regulation. This important shift in perspective pushes us to consider their broader impact on endocrine balance and metabolic processes.[2] This research zeroes in on how elevated calcium levels and Thyroid Stimulating Hormone (TSH) influence parafollicular C-cell hyperplasia and, ultimately, cancer development. Understanding these specific triggers is crucial for clinical practice, helping identify risk factors and guiding preventative strategies or early detection efforts for medullary thyroid carcinoma.[3] This case report highlights an unusual presentation of familial medullary thyroid carcinoma where C-cell hyperplasia was absent, despite the familial link, and no germline RET proto-oncogene mutation was found. What this really means is that our understanding of MTC pathogenesis, especially in familial contexts, still has gaps, and other genetic or environmental factors might be at play.[4] This study is all about using immunohistochemistry to differentiate between parafollicular C-cell hyperplasia and medullary thyroid carcinoma by looking at specific markers like Chromogranin A, Synaptophysin, and Calcitonin. What's useful here is how these markers help pathologists make accurate diagnoses, critical for determining appropriate treatment and patient prognosis. Its a practical application of molecular biology in pathology.[5] Lets break down these new insights into how parafollicular C cell growth and function are regulated. This paper specifically spotlights the roles of Vitamin D and the Calcium Sensing Receptor. This information is a big deal because it reveals new potential pathways for therapeutic interventions, not just for managing calcium levels but possibly for preventing or treating C-cell related pathologies. It gives us a clearer picture of intricate regulatory mechanisms.[6] This study identified a specific transcriptional signature for mouse thyroid parafollicular cells. Having a distinct genetic fingerprint for these cells allows for a more precise understanding of their unique functions and development. This detailed molecular insight is foundational for future research into C-cell specific diseases and potential targeted therapies.[7] This comprehensive review provides an excellent overview of the pathogenesis of medullary thyroid carcinoma and C-cell hyperplasia. It pulls together current knowledge, making it a valuable resource for anyone wanting to understand the molecular and cellular events that lead to these conditions. Its a solid grounding in disease mechanisms, crucial for developing effective diagnostic and therapeutic approaches.[8] This case report discusses a patient with recurrent medullary thyroid carcinoma associated with parafollicular C-cell hyperplasia. This case highlights the potential for recurrence and continued presence of C-cell hyperplasia even after initial treatment. It underscores the need for vigilant follow-up in MTC patients and offers insights into the aggressive nature of these conditions.[9] This article delves into the critical role of parafollicular C cells in maintaining thyroid homeostasis and their involvement in disease states. What this review really means is that these cells are not just bystanders; they are active players in the overall health of the thyroid. Understanding their nuanced contributions is essential for both basic science and clinical approaches to thyroid disorders.[10]
Thyroid C cells, also known as parafollicular cells, are central to thyroid function, exhibiting remarkable plasticity in their origin, development, and adaptation to various physiological needs. This adaptability is critical for understanding general thyroid function and the progression of related diseases, such as medullary thyroid carcinoma (MTC), effectively connecting early developmental stages to later disease states [1]. These cells are not merely bystanders; they are active players in maintaining overall thyroid homeostasis and are significantly involved in disease processes. A deep understanding of their nuanced contributions is essential for both foundational basic science and practical clinical approaches to thyroid disorders [10]. Furthermore, research challenges the traditional view that calcitonin-producing C-cells are solely focused on calcitonin. They actually possess multifaceted roles, contributing to thyroid physiology in ways that extend beyond simple calcium regulation, thus impacting overall endocrine balance and various metabolic processes [2]. Identifying a specific transcriptional signature for mouse thyroid parafollicular cells provides a distinct genetic fingerprint, enabling a more precise understanding of their unique functions and developmental pathways. This detailed molecular insight forms a critical foundation for future research into C-cell specific diseases and potential targeted therapies [7].
Recent insights have significantly advanced our understanding of how parafollicular C cell growth and function are regulated. Specifically, the roles of Vitamin D and the Calcium Sensing Receptor have been spotlighted, revealing new potential pathways for therapeutic interventions. This information is crucial not just for managing calcium levels but also for possibly preventing or treating C-cell related pathologies, offering a much clearer picture of these intricate regulatory mechanisms [6]. Moreover, specific research focuses on how elevated calcium levels and Thyroid Stimulating Hormone (TSH) directly influence parafollicular C-cell hyperplasia and, ultimately, contribute to cancer development. Understanding these precise triggers is paramount for clinical practice, aiding in the identification of risk factors and potentially guiding preventative strategies or early detection efforts for medullary thyroid carcinoma [3]. A comprehensive review synthesizes current knowledge on the pathogenesis of both medullary thyroid carcinoma and C-cell hyperplasia, serving as an invaluable resource for comprehending the molecular and cellular events that lead to these conditions. This solid grounding in disease mechanisms is fundamental for developing truly effective diagnostic and therapeutic approaches [8].
In pathology, immunohistochemistry proves indispensable for differentiating between parafollicular C-cell hyperplasia and medullary thyroid carcinoma. This is achieved by examining specific markers such as Chromogranin A, Synaptophysin, and Calcitonin. The utility of these markers lies in their ability to help pathologists make accurate diagnoses, which is absolutely critical for determining the most appropriate treatment and predicting patient prognosis [5]. However, our comprehension of MTC pathogenesis, especially in familial contexts, still harbors significant gaps. For example, a case report highlighted an unusual presentation of familial medullary thyroid carcinoma where C-cell hyperplasia was conspicuously absent, despite the established familial link, and no germline RET proto-oncogene mutation was identified. This points to the complexity of biology, suggesting that other genetic or environmental factors, not yet fully understood, may be at play [4].
The potential for recurrence in medullary thyroid carcinoma, often associated with parafollicular C-cell hyperplasia, is a significant clinical concern. A case report detailing recurrent MTC with persistent C-cell hyperplasia, even after initial treatment, underscores the aggressive nature of these conditions. This highlights the critical need for vigilant and prolonged follow-up in patients diagnosed with MTC to ensure early detection and management of any recurrences [9].
Thyroid C cells, also called parafollicular cells, are crucial for thyroid function and overall endocrine balance. They show remarkable plasticity, adapting to various physiological demands. Their roles extend beyond simple calcitonin production, with recent insights revealing complex regulatory mechanisms involving factors like Vitamin D and the Calcium Sensing Receptor. These cells are deeply implicated in disease states, particularly medullary thyroid carcinoma (MTC) and C-cell hyperplasia. Research highlights specific triggers for these conditions, such as elevated calcium and Thyroid Stimulating Hormone (TSH), alongside the importance of accurate diagnostic markers like Chromogranin A, Synaptophysin, and Calcitonin for differentiation. The pathogenesis of MTC and C-cell hyperplasia is continuously being elucidated, underscoring the need for understanding their developmental origins. Furthermore, unusual presentations of familial MTC, sometimes lacking C-cell hyperplasia or RET mutations, point to gaps in our knowledge regarding complex genetic and environmental factors. Vigilant follow-up is essential due to the potential for recurrence. Identifying specific transcriptional signatures offers foundational molecular insights, vital for developing targeted therapies and advancing our understanding of these active players in thyroid health and disease.
None
None
1. Bo L, Xiaoyu G, Sijing J. "The origin, development, and plasticity of thyroid C cells".Exp Cell Res 423 (2023):113426.
Indexed at, Google Scholar, Crossref
2. Melike G, Yusuf Y, Ozgur Y. "Calcitonin-producing C-cells: more than just calcitonin".Endocr Regul 57 (2023):214-222.
Indexed at, Google Scholar, Crossref
3. Desiree R, Jiahui Z, Angelo M. "The impact of high calcium and thyroid stimulating hormone on parafollicular C-cell hyperplasia and cancer".Thyroid 31 (2021):477-485.
Indexed at, Google Scholar, Crossref
4. Myrto K, Leonidas S, Maria P. "Familial medullary thyroid carcinoma in the absence of C-cell hyperplasia with no germline RET proto-oncogene mutation".Clin Case Rep 11 (2023):e7436.
Indexed at, Google Scholar, Crossref
5. Farimah A, Reza S, Tayebeh S. "Immunohistochemical Expression of Chromogranin A, Synaptophysin, and Calcitonin in Parafollicular C-Cell Hyperplasia and Medullary Thyroid Carcinoma".Iran J Pathol 17 (2022):371-378.
Indexed at, Google Scholar, Crossref
6. Sile Z, Jing H, Yiran L. "New Insights into the Regulation of Parafollicular C Cell Growth and Function: A Focus on Vitamin D and Calcium Sensing Receptor".Int J Mol Sci 24 (2023):5571.
Indexed at, Google Scholar, Crossref
7. Thomas D, Yasuko M, Charline I. "Identification of a Specific Transcriptional Signature for Mouse Thyroid Parafollicular Cells".Endocrinology 162 (2021):bqab072.
Indexed at, Google Scholar, Crossref
8. Giuseppe P, Marta V, Marianna DP. "Pathogenesis of Medullary Thyroid Carcinoma and C-Cell Hyperplasia: A Comprehensive Review".Cancers (Basel) 14 (2022):4236.
Indexed at, Google Scholar, Crossref
9. Garima S, Varsha S, Shruti S. "Recurrent Medullary Thyroid Carcinoma with Parafollicular C-cell Hyperplasia".JNMA J Nepal Med Assoc 58 (2020):717-720.
Indexed at, Google Scholar, Crossref
10. Martina R, Emilio L, Silvia N. "The Role of Parafollicular C Cells in Thyroid Homeostasis and Disease".Int J Mol Sci 23 (2022):15206.
Reports in Thyroid Research received 4 citations as per Google Scholar report